A detailed history of Marks Group Wealth Management, Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Marks Group Wealth Management, Inc holds 13,629 shares of ZTS stock, worth $2.47 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
13,629
Previous 13,096 4.07%
Holding current value
$2.47 Million
Previous $2.22 Million 6.64%
% of portfolio
0.26%
Previous 0.24%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $77,572 - $95,316
533 Added 4.07%
13,629 $2.36 Million
Q1 2024

Apr 29, 2024

BUY
$165.67 - $199.94 $75,048 - $90,572
453 Added 3.58%
13,096 $2.22 Million
Q4 2023

Feb 01, 2024

BUY
$151.44 - $200.09 $25,290 - $33,415
167 Added 1.34%
12,643 $2.5 Million
Q3 2023

Oct 30, 2023

SELL
$167.14 - $192.77 $31,088 - $35,855
-186 Reduced 1.47%
12,476 $2.17 Million
Q2 2023

Jul 19, 2023

SELL
$160.94 - $186.23 $18,829 - $21,788
-117 Reduced 0.92%
12,662 $2.18 Million
Q1 2023

May 03, 2023

SELL
$145.48 - $175.02 $19,057 - $22,927
-131 Reduced 1.01%
12,779 $2.13 Million
Q4 2022

Feb 06, 2023

SELL
$131.14 - $157.47 $2.65 Million - $3.18 Million
-20,216 Reduced 61.03%
12,910 $1.89 Million
Q3 2022

Nov 10, 2022

BUY
$148.29 - $182.55 $135,833 - $167,215
916 Added 2.84%
33,126 $4.91 Million
Q2 2022

Aug 09, 2022

BUY
$155.97 - $200.09 $153,630 - $197,088
985 Added 3.15%
32,210 $5.54 Million
Q1 2022

May 10, 2022

BUY
$181.39 - $234.03 $416,834 - $537,800
2,298 Added 7.94%
31,225 $5.89 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $42,611 - $54,346
220 Added 0.77%
28,927 $5.39 Million
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $8,518 - $9,436
-45 Reduced 0.16%
28,707 $5.58 Million
Q2 2021

Aug 10, 2021

BUY
$155.9 - $187.99 $57,215 - $68,992
367 Added 1.29%
28,752 $5.36 Million
Q1 2021

May 17, 2021

BUY
$144.0 - $169.39 $220,608 - $259,505
1,532 Added 5.71%
28,385 $4.48 Million
Q4 2020

Feb 08, 2021

BUY
$157.07 - $174.35 $215,657 - $239,382
1,373 Added 5.39%
26,853 $4.44 Million
Q3 2020

Nov 10, 2020

BUY
$137.1 - $165.37 $135,317 - $163,220
987 Added 4.03%
25,480 $4.21 Million
Q2 2020

Aug 10, 2020

BUY
$111.92 - $142.53 $61,779 - $78,676
552 Added 2.31%
24,493 $3.36 Million
Q1 2020

Apr 23, 2020

BUY
$92.66 - $144.94 $70,236 - $109,864
758 Added 3.27%
23,941 $2.81 Million
Q4 2019

Feb 12, 2020

BUY
$116.25 - $133.25 $2.7 Million - $3.09 Million
23,183 New
23,183 $3.07 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Marks Group Wealth Management, Inc Portfolio

Follow Marks Group Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marks Group Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Marks Group Wealth Management, Inc with notifications on news.